Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization

This study has been completed.
Sponsor:
Information provided by:
Biopure Corporation
ClinicalTrials.gov Identifier:
NCT00479895
First received: May 25, 2007
Last updated: May 29, 2008
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)